查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945156

无菌液体处理袋市场按材料类型、容量、应用、最终用户和分销管道划分，全球预测（2026-2032年）

Sterile Liquid Handling Bag Market by Material Type, Capacity, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

无菌液体处理袋市场预计到 2025 年将达到 15.1 亿美元，到 2026 年将成长到 17.1 亿美元，到 2032 年将达到 39.6 亿美元，复合年增长率为 14.77%。

主要市场统计数据
基准年 2025 15.1亿美元
预计年份：2026年 17.1亿美元
预测年份：2032年 39.6亿美元
复合年增长率 (%) 14.77%

策略实施旨在明确无菌液体处理袋在临床工作流程、供应链、法规环境和创新中的作用。

无菌液体处理袋已从简单的容器产品发展成为临床护理、实验室工作流程和生物製程操作的核心组件。本导言概述了这些一次性系统如何与病人安全、供应链连续性和技术驱动的工作流程相联繫，并建立了贯穿本研究的分析框架。

拥抱变革，透过创新材料、数位化、精实生产和不断发展的临床工作流程，重新定义无菌液体处理袋。

无菌液体处理袋领域正经历一场变革，这主要得益于材料科学、製造自动化和数位化整合技术的同步发展。材料创新，特别是从传统PVC配方转变为非PVC结构的转变，解决了人们对增塑剂、萃取物以及与现代无菌和储存条件相容性的担忧。伴随材料变革而来的是生产技术的进步，使得製造更薄、多层、具有客製化阻隔性能和机械耐久性的薄膜成为可能。

评估2025年美国关税及其对无菌液体处理袋的采购、供应链韧性、监管负担和国际贸易的影响

2025年美国关税政策为无菌液体处理袋的製造商、经销商和终端用户带来了新的挑战。在生产层面，进口聚合物、薄膜基材或成品组件的关税将增加投入成本，并可能改变采购决策。许多製造商正在透过重新评估供应商关係、尽可能增加近岸或国内采购以及谈判长期合约来应对这些挑战，以稳定供应并应对价格波动。

细分市场洞察揭示了材料、应用、终端用户环境、销售范围和分销管道如何影响产品优先顺序和商业性重点。

市场区隔旨在识别需求领域以及创新能够创造最大商业性价值的领域。从材料角度来看，市场分为非PVC结构和PVC结构，非PVC结构进一步细分为多层设计以及聚乙烯和聚丙烯等不同类型。这些材料选择反映了对阻隔性能、化学相容性和法规遵循的优先考虑。应用细分涵盖血液采集、细胞培养、引流、输液和清洁，每种应用场景对连接器类型、生物相容性和无菌操作方法都有独特的要求。

区域分析比较了美洲、欧洲、中东、非洲和亚太地区的需求驱动因素、法规环境、生产能力和招聘趋势。

区域趋势对产品设计、监管策略和商业性执行有显着影响。在美洲，采购往往倾向于那些既能遵守监管规定又能提供灵活物流的供应商，而创新则是由大型医疗保健系统和不断扩展的专业製造地网络共同驱动的。法规环境强调基于风险的评估和上市后监测，对于业务遍及多个州的供应商而言，可追溯性和无菌保证的重要性日益凸显。

关键公司层面洞察，重点在于领先供应商的竞争考察、创新重点、伙伴关係策略、垂直整合措施和差异化策略

企业层面的发展趋势着重于透过材料创新、生产规模化和策略联盟实现供应商差异化。主要企业正投入研发资源，以减少可萃取物、扩大无PVC薄膜的使用，并设计兼顾柔软性和阻隔保护的多层结构。同时，契约製造製造商也在扩大产能，以满足品牌所有者在保证品质和合规性的同时外包生产的需求。

为产业领导者提供切实可行的策略建议，以加速产品创新、优化采购、加强合规性并扩大临床应用。

行业领导者应采取一系列措施，在降低供应和监管风险的同时创造价值。首先，应加快材料多样化，在临床适用的情况下，对非PVC多层材料、PE和PP结构进行认证，同时保持合格的萃取物和相容性测试，以满足医疗专业人员的期望。这将减少对单一树脂的依赖，并使产品供应与永续性和安全性优先事项保持一致。

一种透明的调查方法，结合了关键相关人员访谈、供应商分析、技术检验和多源资料三角测量。

本调查方法结合了结构化的初步研究和严谨的二次检验技术分析。初步资料收集包括对采购主管、临床终端使用者、监管专家和生产主管的访谈，以了解实际挑战、采购标准和创新重点。访谈结果用于建构生态系统图，识别各区域的关键供应商、契约製造製造商和分销合作伙伴。

对推动无菌液体处理袋创新和应用的相关人员的策略重点、核心风险和机会管道进行权威的综合分析。

分析表明，无菌液体处理袋领域正处于材料科学创新、供应链实际应对措施和不断变化的临床需求三者交汇点。相关人员将更有利于抓住市场机会，而相关人员投资于健全的采购系统和数位化可追溯性的利益相关者则能够降低贸易中断和品质风险。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 依材料类型分類的无菌液体处理袋市场

  • 不含聚氯乙烯
    • 多层结构
    • PE
    • PP
  • PVC

9. 无菌液体处理袋市场（以销售量计）

  • 500～1,000ml
  • 500毫升或以下
  • 超过1000毫升

第十章 无菌液体处理袋市场按应用领域划分

  • 血液收集
  • 细胞培养
  • 引流
  • 点滴
  • 打扫

第十一章 无菌液体处理袋市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院
  • 研究所

第十二章 无菌液体处理袋市场（依通路划分）

  • 离线
  • 在线的

第十三章 无菌液体处理袋市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 无菌液体处理袋市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国无菌液体处理袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国无菌液体处理袋市场

第十七章：中国无菌液体处理袋市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ABEC Inc
  • Agilent Technologies Inc
  • Avantor Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson and Company
  • Corning Incorporated
  • Danaher Corporation
  • Entegris Inc
  • Eppendorf SE
  • Fresenius Kabi AG
  • Fujimori Kogyo Co Ltd
  • GEA Group AG
  • Gilson Inc
  • Grifols SA
  • Hamilton Company
  • ICU Medical Inc
  • Lonza Group AG
  • Meissner Filtration Products Inc
  • Merck KGaA
  • Nipro Corporation
  • Poly Medicure Limited
  • Repligen Corporation
  • Saint-Gobain
  • Sartorius AG
  • Single Use Support GmbH
  • Tecan Group Ltd
  • Terumo Corporation
  • Thermo Fisher Scientific Inc
  • VWR International LLC
Product Code: MRR-3F575F195241

The Sterile Liquid Handling Bag Market was valued at USD 1.51 billion in 2025 and is projected to grow to USD 1.71 billion in 2026, with a CAGR of 14.77%, reaching USD 3.96 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.51 billion
Estimated Year [2026] USD 1.71 billion
Forecast Year [2032] USD 3.96 billion
CAGR (%) 14.77%

A strategic introduction framing the role of sterile liquid handling bags across clinical workflows, supply chains, regulatory conditions, and innovation

The sterile liquid handling bag has evolved from a simple containment product into a pivotal component across clinical care, laboratory workflows, and bioprocessing operations. This introduction outlines how these disposable systems intersect with patient safety, supply-chain continuity, and technology-enabled workflows while establishing the analytical framework used throughout the study.

Sterility, material compatibility, and ease of handling are core attributes that define the product class, but their importance is amplified by contemporaneous demands: tighter regulatory expectations, rising preference for single-use technologies in infection control, and clinical teams seeking reliable, ergonomically designed consumables. In parallel, manufacturers face pressures to innovate on materials and manufacturing processes to reduce extractables, improve barrier properties, and deliver consistent performance under sterilization.

The following analysis situates these technical and commercial dynamics within the broader ecosystem of clinicians, procurement professionals, contract manufacturers, and distributors. By clarifying the intersections among materials science, clinical needs, and supply continuity, this introduction primes decision-makers to understand the strategic levers that will shape future product development and market positioning.

Capturing transformative shifts redefining sterile liquid handling bags through novel materials, digitalization, lean manufacturing and evolving clinical workflows

The sterile liquid handling bag landscape is experiencing catalytic shifts driven by simultaneous advances in material science, manufacturing automation, and digital integration. Materials innovation-particularly the pivot from legacy PVC formulations to non-PVC constructions-addresses concerns about plasticizers, extractables, and compatibility with modern sterilization and storage regimes. This materials evolution is accompanied by production technologies that enable thinner, multi-layer films with tailored barrier properties and improved mechanical resilience.

Concurrently, digital technologies are being embedded across manufacturing and supply chains to improve traceability, lot-level visibility, and quality control. Smart labeling, enhanced serialization, and integration with electronic inventory systems reduce the risk of counterfeits, enable faster recall management, and support clinical workflows that demand real-time stock data. Manufacturing-level automation and continuous-production approaches compress lead times and increase consistency, which is particularly valuable where single-use components are subject to rigorous sterility requirements.

Finally, clinical demand patterns are shifting: heightened focus on infection prevention, adoption of single-use bioprocessing in research and production, and the need for flexible fluid management solutions in ambulatory and decentralized care settings. Together, these transformative forces are reshaping product roadmaps, procurement strategies, and partnership models across the value chain.

Assessing United States tariffs in 2025 and their effects on sterile liquid handling bag sourcing, supply chain resilience, regulatory burden, and global trade

United States tariff actions in 2025 have introduced a new layer of complexity for manufacturers, distributors, and end users of sterile liquid handling bags. At the production level, tariffs on imported polymers, film substrates, or finished components can increase input costs and alter sourcing decisions. Many manufacturers respond by reassessing supplier relationships, expanding nearshore or domestic sourcing where feasible, and negotiating long-term agreements that stabilize supply and price volatility.

Tariff-driven cost pressures ripple through procurement and clinical channels. Health systems and research institutions may encounter higher unit prices or reconfigured purchasing agreements, prompting procurement teams to re-evaluate total cost of ownership, vendor consolidation strategies, and inventory policies. In some cases, buyers will prioritize suppliers with localized production or vertically integrated operations that can shield them from cross-border tariff exposure.

Regulatory and compliance activities intersect with tariff impacts. Changes to supply chains often necessitate additional validation, updated supplier audits, and revised documentation to ensure materials and sterilization processes remain compliant with applicable standards. For organizations that rely on just-in-time inventories, tariffs can amplify the importance of contingency planning and risk mitigation, encouraging investments in buffer stocks, alternate suppliers, and collaborative forecasting with strategic partners.

In the aggregate, tariffs are accelerating supply-chain diversification, incentivizing investment in domestic capabilities, and elevating the strategic importance of procurement resilience and regulatory agility across the sterile liquid handling bag ecosystem.

Segmentation insights showing how materials, applications, end-user settings, capacity ranges and channels shape product priorities and commercial focus

Segmentation clarifies where demand concentrates and where innovation can deliver the most commercial value. From a materials perspective, the market differentiates between Non-PVC and PVC constructions, with Non-PVC further subdivided into multi-layer designs as well as polyethylene and polypropylene variants; the choice among these materials reflects priorities around barrier performance, chemical compatibility, and regulatory acceptability. Application segmentation spans blood collection, cell culture, drainage, infusion, and irrigation, each use case imposing distinct requirements for connector types, biocompatibility, and sterilization methods.

End-user segmentation differentiates ambulatory surgical centers, clinics, hospitals, and research laboratories, with procurement strategies and clinical handling practices varying substantially across these settings. Capacity segmentation includes small-volume offerings under 500 mL, mid-range 500-1000 mL formats, and larger bags exceeding 1000 mL; capacity decisions are driven by clinical protocols, storage constraints, and single-use versus batch-processing modalities. Distribution channels encompass direct sales relationships, third-party distributors, online procurement platforms, and retail pharmacies, all of which shape pricing structures, lead times, and service expectations.

Understanding the interplay among material choices, application needs, user environments, capacity preferences, and distribution pathways allows suppliers to prioritize formulation R&D, tailor commercial models, and design packaging and labeling that reduce adoption friction in target segments.

Regional insights that compare demand drivers, regulatory environments, production capacity, and adoption trends across the Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence product design, regulatory strategy, and commercial execution. In the Americas, procurement tends to favor suppliers that combine regulatory compliance with responsive logistics, while innovation is driven by a mix of large health systems and a growing network of specialty biomanufacturing sites. The regulatory environment emphasizes risk-based evaluation and post-market surveillance, which elevates the importance of traceability and sterility assurance for suppliers operating across multiple states.

Europe, the Middle East & Africa (EMEA) presents a heterogeneous regulatory landscape where harmonization efforts coexist with country-level variances; suppliers must navigate regional device regulations, stringent environmental standards, and an increased focus on sustainability that influences material selection and end-of-life considerations. Distribution models in EMEA often hinge on established distributor networks and tender processes that reward proven clinical performance and regulatory clarity.

Asia-Pacific demonstrates fast-paced capacity expansion, with several markets prioritizing domestic manufacturing and scale-up to support local healthcare infrastructure and export ambitions. Adoption in the region is propelled by investments in ambulatory care and laboratory facilities, but suppliers must adapt to diverse reimbursement frameworks and varying regulatory pathways. Across all regions, strategic decisions around manufacturing footprint, regulatory submissions, and commercial partnerships are central to maximizing reach and minimizing supply disruption.

Key company-level insights highlighting competitive dynamics, innovation priorities, partnership strategies, vertical integration moves, and differentiation tactics among leading suppliers

Company-level dynamics center on how suppliers differentiate through material innovation, manufacturing scale, and strategic partnerships. Leading manufacturers are allocating R&D resources to reduce extractables, broaden the use of non-PVC films, and engineer multi-layer constructions that balance flexibility with barrier protection. At the same time, contract manufacturing organizations are expanding capacity to serve brand owners seeking to outsource production while preserving quality and compliance.

Competitive positioning increasingly depends on a combination of vertical integration and collaborative ecosystems. Firms that control polymer supply, film extrusion, bag fabrication, and sterilization can offer shorter lead times and more predictable quality; conversely, companies that excel in rapid innovation often partner with specialized film producers and academic labs to accelerate material qualification. Partnerships with logistics providers, distributors, and clinical training organizations further extend reach and reduce adoption friction in complex health systems.

Mergers, strategic alliances, and selective investments in capacity are common tactics to secure supply, access new geographies, and lock in procurement channels. Companies that emphasize clear regulatory pathways, demonstrable clinical performance, and supply continuity gain trust with institutional buyers and stand a greater chance of securing preferred-supplier arrangements.

Actionable strategic recommendations for industry leaders to accelerate product innovation, optimize sourcing, strengthen compliance, and expand clinical adoption

Industry leaders should adopt a portfolio of actions to capture value while mitigating supply and regulatory risks. First, accelerate materials diversification by qualifying non-PVC multi-layer, PE, and PP constructions where clinically appropriate, while maintaining robust extractables and compatibility testing to meet clinician expectations. Doing so reduces dependency on a single resin stream and aligns product offerings with sustainability and safety priorities.

Second, invest in supply-chain resilience through a blend of nearshoring, strategic dual-sourcing, and capacity agreements with contract manufacturers to mitigate tariff and logistics exposures. Complement those investments with enhanced traceability-serialisation and digital lot tracking-to improve recall responsiveness and satisfy procurement risk assessments. Third, tailor commercial models to end-user needs by offering differentiated packaging and capacity formats for ambulatory surgical centers, clinics, hospitals, and research labs, and by aligning distribution strategies across direct sales, distributors, online channels, and retail pharmacy pathways.

Finally, prioritize regulatory and quality investments that expedite approvals and reduce time-to-adoption. Engage early with regulatory bodies on novel materials and new sterilization regimes, and consider collaborative post-market studies with healthcare partners to demonstrate real-world performance. These actions, taken together, will help organizations convert technical advances into durable commercial advantage.

Transparent research methodology combining primary stakeholder interviews, supplier mapping, technical validation, and multi-source data triangulation

The research methodology combines structured primary engagement with rigorous secondary validation and technical analysis. Primary data collection included interviews with procurement leaders, clinical end users, regulatory specialists, and manufacturing executives to capture real-world challenges, procurement criteria, and innovation priorities. These interviews informed an ecosystem map that identified critical suppliers, contract manufacturers, and distribution partners across geographies.

Secondary research provided context on regulatory frameworks, material science developments, and published device guidance, while laboratory-level technical validation reviewed material compatibility, sterilization performance, and handling ergonomics. Data triangulation reconciled disparate inputs-qualitative interview findings, technical lab results, and supply-chain observations-to ensure consistent conclusions. Quality controls included reviewer cross-checks, replicate interviews where discrepancies emerged, and targeted follow-ups to clarify ambiguous or conflicting evidence.

This layered approach ensures that findings reflect both the operational realities of healthcare delivery and the technical constraints of materials and manufacturing, providing leaders with defensible insights they can act upon.

A conclusive synthesis of strategic priorities, core risks, and opportunity pathways for stakeholders driving sterile liquid handling bag innovation and uptake

The analysis concludes that the sterile liquid handling bag sector sits at the intersection of material science innovation, supply-chain pragmatism, and shifting clinical priorities. Stakeholders who align materials strategy with regulatory expectations and clinical needs will be best positioned to capture adoption opportunities, while those who invest in resilient sourcing and digital traceability will reduce exposure to trade disruptions and quality risk.

Risk vectors to monitor include tariff environments, single-sourced resin dependencies, and evolving sterilization and compatibility standards that could affect product acceptability. Opportunity pathways include targeted R&D into non-PVC multi-layer solutions, expansion into high-growth clinical and research segments, and platform strategies that integrate disposables with digital inventory and quality systems. By synthesizing these priorities into a coherent plan-balancing innovation investment with operational resilience-organizations can translate technical capability into sustained commercial performance.

Decision-makers should prioritize actions that deliver both short-term stability and long-term differentiation, ensuring procurement, regulatory, and R&D teams coordinate around common objectives to accelerate adoption and reduce systemic risk.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sterile Liquid Handling Bag Market, by Material Type

  • 8.1. Non-PVC
    • 8.1.1. Multi-Layer
    • 8.1.2. PE
    • 8.1.3. PP
  • 8.2. PVC

9. Sterile Liquid Handling Bag Market, by Capacity

  • 9.1. 500-1000 Ml
  • 9.2. <500 Ml
  • 9.3. >1000 Ml

10. Sterile Liquid Handling Bag Market, by Application

  • 10.1. Blood Collection
  • 10.2. Cell Culture
  • 10.3. Drainage
  • 10.4. Infusion
  • 10.5. Irrigation

11. Sterile Liquid Handling Bag Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Research Laboratories

12. Sterile Liquid Handling Bag Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Sterile Liquid Handling Bag Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sterile Liquid Handling Bag Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sterile Liquid Handling Bag Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Sterile Liquid Handling Bag Market

17. China Sterile Liquid Handling Bag Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ABEC Inc
  • 18.6. Agilent Technologies Inc
  • 18.7. Avantor Inc
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc
  • 18.10. Becton Dickinson and Company
  • 18.11. Corning Incorporated
  • 18.12. Danaher Corporation
  • 18.13. Entegris Inc
  • 18.14. Eppendorf SE
  • 18.15. Fresenius Kabi AG
  • 18.16. Fujimori Kogyo Co Ltd
  • 18.17. GEA Group AG
  • 18.18. Gilson Inc
  • 18.19. Grifols S.A.
  • 18.20. Hamilton Company
  • 18.21. ICU Medical Inc
  • 18.22. Lonza Group AG
  • 18.23. Meissner Filtration Products Inc
  • 18.24. Merck KGaA
  • 18.25. Nipro Corporation
  • 18.26. Poly Medicure Limited
  • 18.27. Repligen Corporation
  • 18.28. Saint-Gobain
  • 18.29. Sartorius AG
  • 18.30. Single Use Support GmbH
  • 18.31. Tecan Group Ltd
  • 18.32. Terumo Corporation
  • 18.33. Thermo Fisher Scientific Inc
  • 18.34. VWR International LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STERILE LIQUID HANDLING BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STERILE LIQUID HANDLING BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MULTI-LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MULTI-LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY MULTI-LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY 500-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY 500-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY 500-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY <500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY <500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY <500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY >1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY >1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY >1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY IRRIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY IRRIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY IRRIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 133. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 154. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 161. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL STERILE LIQUID HANDLING BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA STERILE LIQUID HANDLING BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)